Stuart Naylor
Fortuna: 8 M $ al 31/07/2026
Fortuna: 8 M $ al 31/07/2026
Stuart Naylor is Chief Development Officer at MeiraGTx Holdings Plc since 2019.
Formerly, Dr. Naylor was Chief Executive Officer at MeiraGTx UK II Ltd. from 2015 to 2016, Managing Director at Coltivare Ltd. from 2013 to 2015, and Chief Scientific Officer & Executive Director at Oxford Biomedica Plc from 2010 to 2013.
Education includes undergraduate studies at the University of Warwick and graduate studies at King's College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEIRAGTX HOLDINGS PLC 0,69 % | 07/07/2026 | 640.846 ( 0,69 % ) | 8 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Corporate Officer/Principal | 01/04/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
MeiraGTx UK II Ltd.
MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Director Ejecutivo | 01/04/2016 |
Coltivare Ltd.
Coltivare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Director Ejecutivo | 01/04/2015 |
| OXFORD BIOMEDICA PLC | Director Técnico/Científico/I+D | 06/06/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Holdings Plc
MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
MeiraGTx UK II Ltd.
MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Health Technology |
Coltivare Ltd.
Coltivare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.